Cancer vaccines: The next generation of tools to monitor the anticancer immune response

PLoS Medicine

Volumn 2, Issue 10, 2005, Pages 0951-0952

  Nestle, Frank O ^a   Tonel, Giulia ^a   Farkas, Arpad ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER CELL; CANCER PREVENTION; CELL DAMAGE; DRUG MECHANISM; DRUG MONITORING; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGY; SHORT SURVEY; VACCINATION; BIOASSAY; HUMAN; IMMUNOASSAY; NEOPLASM; PHYSIOLOGY; REVIEW;

BIOLOGICAL MARKERS; CANCER VACCINES; ENDPOINT DETERMINATION; HUMANS; IMMUNE SYSTEM; IMMUNOASSAY; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; VACCINATION;

EID: 27644441844     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020339     Document Type: Short Survey

References (12)

1. Rastetter W, Molina A, White CA (2004) Rituximab: Expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 55: 477-503.
2. Bleakley M, Riddell SR (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 4: 371-380.
3. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213.
4. Nestle FO, Farkas A, Conrad C (2005) Dendritic-cell-based therapeutic vaccination against cancer. Curr Opin Immunol 17: 163-169.
5. Cerundolo V, Hermans IF, Salio M (2004) Dendritic cells: A journey from laboratory to clinic. Nat Immunol 5: 7-10.
6. Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, et al. (2002) Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med 195: 1279-1288.
7. Gilliet M, Kleinhans M, Lantelme E, Schadendorf D, Burg G, et al. (2003) Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood 102: 36-42.
8. Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, et al. (2005) High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J Exp Med 201: 241-248.
9. Speiser DE (2005) Immunological techniques: Ex vivo characterization of T cell-mediated immune responses in cancer. Curr Opin Immunol 17: 419-422.
10. Chen DS, Davis MM (2005) Cellular immunotherapy: Antigen recognition is just the beginning. Springer Semin Immunopathol 27: 119-127.
11. Hernandez-Fuentes MP, Warrens AN, Lechler RI (2003) Immunologic monitoring. Immunol Rev 196: 247-264.
12. Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78: 5535-5545.